Join
Live feed
·
INSIDERFilingvia Quantisnow
Alzamend Neuro Inc. logo

Director Mcgrath Lynne Fahey sold $69 worth of shares (30 units at $2.29), decreasing direct ownership by 55% to 25 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ALZN· Alzamend Neuro Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALZN (Alzamend Neuro Inc.) and more on Quantisnow.